These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 203349

  • 21. Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts.
    Kiessling R, Hochman PS, Haller O, Shearer GM, Wigzell H, Cudkowicz G.
    Eur J Immunol; 1977 Sep; 7(9):655-63. PubMed ID: 336380
    [No Abstract] [Full Text] [Related]

  • 22. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C, George T, Devora GA, Morris MA, Gordon BE, Kumar V, Bennett M.
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
    [Abstract] [Full Text] [Related]

  • 23. Acute rejection of marrow grafts in mice. Dependence on and independence of functional TCR in the rejection process.
    Takeda K, Moore MW, Dennert G.
    J Immunol; 1994 May 01; 152(9):4407-16. PubMed ID: 8157961
    [Abstract] [Full Text] [Related]

  • 24. An absence of T cells in murine bone marrow allografts leads to an increased susceptibility to rejection by natural killer cells and T cells.
    Murphy WJ, Kumar V, Cope JC, Bennett M.
    J Immunol; 1990 May 01; 144(9):3305-11. PubMed ID: 2329274
    [Abstract] [Full Text] [Related]

  • 25. Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease.
    Azuma E, Yamamoto H, Kaplan J.
    J Immunol; 1989 Sep 01; 143(5):1524-9. PubMed ID: 2668409
    [Abstract] [Full Text] [Related]

  • 26. Bone marrow allograft rejection mediated by a novel murine NK receptor, NKG2I.
    Koike J, Wakao H, Ishizuka Y, Sato TA, Hamaoki M, Seino K, Koseki H, Nakayama T, Taniguchi M.
    J Exp Med; 2004 Jan 05; 199(1):137-44. PubMed ID: 14707119
    [Abstract] [Full Text] [Related]

  • 27. Joint influence of natural killers (NK) and hemopoietic stroma on rejection of parent stem cells.
    Pirozhkov A, Dozmorov I, Petrov R.
    Bone Marrow Transplant; 1995 Nov 05; 16(5):683-93. PubMed ID: 8547866
    [Abstract] [Full Text] [Related]

  • 28. "Xenogeneic resistance" to rat bone marrow transplantation. III. Maturation age, and abrogation with cyclophosphamide, Corynebacterium parvum and fractionated irradiation.
    Rauchwerger JM, Gallagher MT, Monié HJ, Trentin JJ.
    Biomedicine; 1976 Jan 05; 24(1):20-5. PubMed ID: 773442
    [Abstract] [Full Text] [Related]

  • 29. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
    Raziuddin A, Longo DL, Mason L, Ortaldo JR, Bennett M, Murphy WJ.
    J Immunol; 1998 Jan 01; 160(1):87-94. PubMed ID: 9551959
    [Abstract] [Full Text] [Related]

  • 30. Effector cell expression of NK1.1, a murine natural killer cell-specific molecule, and ability of mice to reject bone marrow allografts.
    Sentman CL, Kumar V, Koo G, Bennett M.
    J Immunol; 1989 Mar 15; 142(6):1847-53. PubMed ID: 2646375
    [Abstract] [Full Text] [Related]

  • 31. Evidence for a role for T cell receptors (TCR) in the effector phase of acute bone marrow graft rejection. TCR V beta 5 transgenic mice lack effector cells able to cause graft rejection.
    Kikly K, Dennert G.
    J Immunol; 1992 Dec 01; 149(11):3489-94. PubMed ID: 1431119
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Hybrid and allogeneic resistance to T cell grafts mediated by murine NK and CD8+ T cells.
    Davenport C, Haile A, Kumar V, Bennett M.
    J Immunol; 1995 Mar 15; 154(6):2568-77. PubMed ID: 7876533
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O, Longo DL, Tian ZG, Hornung RL, Taub DD, Ruscetti FW, Murphy WJ.
    J Clin Invest; 1998 May 01; 101(9):1835-42. PubMed ID: 9576746
    [Abstract] [Full Text] [Related]

  • 37. The role of natural killer cells in resistance to allogeneic and parental hybrid resistance.
    Waterfall M, Rayfield LS, Brent L.
    Transplantation; 1987 Feb 01; 43(2):312-4. PubMed ID: 3544391
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Mesenchymal stem cells enhance xenochimerism in NK-depleted hosts.
    Moadsiri A, Polchert D, Genrich K, Napoles P, Reina E, Turian J, Smith B, Bartholomew A.
    Surgery; 2006 Aug 01; 140(2):315-21. PubMed ID: 16904985
    [Abstract] [Full Text] [Related]

  • 40. Resistance to parental, allogeneic and xenogeneic hemopoietic grafts in irradiated mice.
    Lotzová E.
    Exp Hematol; 1977 May 01; 5(3):215-35. PubMed ID: 326573
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.